We are the Peptide Experts

JPT Peptide Technologies is the leading manufacturer of custom peptides and innovative peptide-based products for research and clinical applications. For more than 15 years we have been serving the worldwide biomedical community with science and quality driven products and services.

Located in our state-of-the-art laboratories in Berlin, Germany, JPT operates according to the most recent ISO 9001:2015 regulations.

Custom Peptide Synthesis

Our Quality Guarantee

Since 2004 JPT maintains an active quality management system that is annually reviewed, audited and certified by an independent certifcation body (TÜV Rheinland) to meet ISO 9001 standards. Therefore, we have installed complete process documentation and an early signaling procedure in case of problems.

Product Finder

Search by scientific field

Research Fields

Cell Therapy & Vaccines

Cell Therapy & Vaccines

JPT offers a large portfolio of peptide products and services supporting all development phases of new cell therapies and vaccines. These products range from discovery tools for epitope and target identification, to various peptide formats for immune monitoring and clinical grade peptides to support clinical vaccination and cell therapy trials.  Learn more


JPT has developed a variety of unique peptide-based products allowing systematic evaluation of cellular and humoral immunity. In addition to peptide formats allowing T-cell and B-cell epitope discovery, antigen-specific T-cell stimulation and immune monitoring our clinical grade products support clinical trials for the development of new immunotherapeutics and vaccines. Learn more
Neo-Epitope Discovery & Therapy

Neo-Epitope Discovery & Therapy

Neo-epitopes are important targets for individualized cancer immunotherapy. JPT’s high-throughput peptide techniques enable access to customized peptide products for neo-epitope prioritization and validation, individualized therapy development and immune monitoring. Learn more


Proteomics is the study of a cell's protein inventory at different times by protein identification and quantification. The application of mass spectrometry and more specifically LC-MS/MS has tremendously facilitated this process. JPT developed proprietary approaches for the provision of quantified custom peptides and ready-to-use products enabling protein biomarker identification and quantitation. Learn more


JPT was the first company responding to the Covid-19 pandemic with the launch of a broad SARS CoV-2 genome spanning portfolio of peptide tools. The ready to use and custom peptide tools include antigen spanning PepMixTM peptide pools and PepStarTM peptide microarrays of SARS-CoV-2 wild type and mutated antigen sequences as well as antigens from other relevant corona viruses.  Learn more


Now available: PepMix Peptide Pools for Spike BA.4/BA.5
Omicron BA.5 is now the dominant SARS-CoV-2 variant all over the world. Therefore, we announce the addition of 
  • PepMix SARS-CoV-2 (Spike / BA.4/BA.5 / Omicron)
  • PepMix SARS-CoV-2 (S-RBD / BA.4/BA.5 / Omicron)
August 2022

JPT's Proteomic Products at Work: Recent Publications!
JPT has been providing innovative peptide tools such as reference peptides and kits to the proteomics community for many years.  Here we proudly present selected and most recent proteomics publications with contribution of our unique reference peptide formats.
July 2022

Monkeypox & Vaccinia Peptide Pools  & Microarrays! 
With the recent emergence of a new monkeypox strain, questions about its severity and potential spread among humans remain to be answered. To study cross immunity and monitor immune cell activity, our R&D Team developed a  PepMix Pan-Poxviridae Select Peptide Pool.

July  2022

Check our list of products, click and go.

Get a quote